Gao, Chengjie
Tao, Yijing
Qian, Da
Zhou, Yafeng
Funding for this research was provided by:
Hospital-level exploratory clinical research projects in Shanghai Sixth People’s Hospital (ynts 202107)
Changshu Health Commission Science and Technology Program of 2022 (CSWSQ202203)
Changshu Science and Technology Program of 2023 (CY202301)
National Natural Science Foundation of China (81873486)
Science and Technology Development Program of Jiangsu Province-Clinical Frontier Technology (BE2022754)
Clinical Medicine Expert Team (Class A) of Jinji Lake Health Talents Program of Suzhou Industrial Park (SZYQTD202102)
Suzhou Key Discipline for Medicine (SZXK202129)
Demonstration of Scientific and Technological Innovation Project (SKY2021002)
Suzhou Dedicated Project on Diagnosis and Treatment Technology of Major Diseases (LCZX202132)
Research on Collaborative Innovation of medical engineering combination (SZM2021014)
Suzhou Key Laboratory of Diagnosis and Treatment of Panvascular Diseases (SZS2023021)
Article History
Received: 9 October 2024
Accepted: 24 July 2025
First Online: 11 August 2025
Declarations
:
: The protocol for this research was approved by the Shanghai Chedun Experimental Animal Ethics Committee (approval number: AD20220311). All animal experiments were performed in accordance with the guidelines of the National Institute of Health Guide for the Care and Use of Laboratory Animals (NIH publication 8023, revised 1996) under the approval of the Shanghai Chedun Experimental Animal Ethics Committee.
: Not applicable.
: The authors declare no competing interests.